Abstract
This paper reviews recent experimental evidence in support of inoculation with antirabies serum, the value of which, as a prophylactic measure, is compared with that of vaccine treatment alone. The author concludes that the chief advantages of combined antiserum-vaccine prophylaxis lie in the rapid treatment of cases who have suffered severe exposure, and in the possibility of reducing the incidence of post-vaccinal complications.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- KOPROWSKI H., COX H. R. Recent developments in the prophylaxis of rabies. Am J Public Health Nations Health. 1951 Dec;41(12):1483–1489. doi: 10.2105/ajph.41.12.1483. [DOI] [PMC free article] [PubMed] [Google Scholar]
- KOPROWSKI H., VAN DER SCHEER J., BLACK J. Use of hyperimmune anti-rabies serum concentrates in experimental rabies. Am J Med. 1950 Apr;8(4):412–420. doi: 10.1016/0002-9343(50)90224-5. [DOI] [PubMed] [Google Scholar]